BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 10, 2004
View Archived Issues
Cosmetic improvements induced by the Isolagen Process in the treatment of facial wrinkles and scars
Read More
LyphoDerm reported more effective than standard of care in venous leg ulcers
Read More
Significant antihypertensive effects reported for omapatrilat in the OCTAVE trial
Read More
ThromboGenics and Geymonat to codevelop placental growth factor
Read More
Pivotal trial planned for pixantrone for relapsed, aggressive NHL
Read More
BMS Medical Imaging and Kereos to develop novel molecular imaging agents
Read More
Research phase for development of atherosclerosis therapeutic
Read More
Ipsen acquires Sterix
Read More
ICE inhibitor pralnacasan prevents dextran sulfate sodium-induced colitis in mice
Read More
Antiinflammatory effects of the PDE4 inhibitor AWD-12-281 shown in human cell preparations
Read More
N-Myristoyltransferase inhibitors: Potential anticancer agents
Read More
SBIR grant supports development of GelVac intranasal vaccine delivery platform
Read More
Completion of patient enrollment announced for a trial on I2S in Hunter syndrome
Read More
New PARP inhibitors prepared and tested at Kyorin
Read More
Novel agents able to induce neural stem cell differentiation into neurons
Read More
New DPP-IV inhibitors developed by Yamanouchi scientists
Read More
Novel calpain inhibitors and their use in stroke, ocular disorders, etc. reported by Senju
Read More
New antiandrogenic agents in early development at Yamanouchi
Read More
Janssen claims new quinoline-based antimycobacterial agents
Read More
Two series of PPARalpha agonists presented by Merck scientists
Read More
Seikagaku patent covers GalNAc4S6ST inhibitors and their use
Read More
IND clearance allows initiation of clinical studies for ARRY-142886
Read More
Additional phase III data in support of TTFC
Read More
Data reported from Viramidine phase II trial
Read More
Foradil Certihaler receives Swiss approval
Read More
Expansion of Sankyo/Tularik GPCR collaboration
Read More
Enrollment progresses in first phase III study for Oxytrex
Read More
Enrollment under way in phase II trial of Aurexis
Read More
Cloretazine receives fast track status for AML
Read More